- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Guardian Pharmacy Services Inc (GRDN)
Guardian Pharmacy Services Inc stock price live, this page displays NYSE GRDN stock exchange data. View the GRDN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Guardian Pharmacy Services Inc real time stock price chart below.
What Is the Guardian Pharmacy Services Inc Stock Price Today?
The Guardian Pharmacy Services Inc stock price today is 38.43.
What Is the Stock Symbol for Guardian Pharmacy Services Inc?
The stock symbol for Guardian Pharmacy Services Inc is "GRDN."
What Stock Exchange Does Guardian Pharmacy Services Inc Trade On?
Guardian Pharmacy Services Inc is listed and trades on the NYSE stock exchange.
Is Guardian Pharmacy Services Inc a Good Stock to Buy?
Determining whether Guardian Pharmacy Services Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRDN quote. (ISIN: US40145W1018)
What Is the Guardian Pharmacy Services Inc Stock Price Today?
The Guardian Pharmacy Services Inc stock price today is 38.43.
What Is the Stock Symbol for Guardian Pharmacy Services Inc?
The stock symbol for Guardian Pharmacy Services Inc is "GRDN."
What Stock Exchange Does Guardian Pharmacy Services Inc Trade On?
Guardian Pharmacy Services Inc is listed and trades on the NYSE stock exchange.
Is Guardian Pharmacy Services Inc a Good Stock to Buy?
Determining whether Guardian Pharmacy Services Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRDN quote. (ISIN: US40145W1018)
NYSE
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
37.58
39.05
52 wk Range
23.14
47.02
GRDN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
37.5839.05
52 wk Range
23.1447.02
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GRDN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
48.83
Upside
+27.07%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 48.83
(+27.07% Upside)
Guardian Pharmacy Services Inc Earnings Call Summary for Q2/2026
- Guardian Pharmacy Q2 revenue rose 2% to $351.2M, constrained by IRA pricing cuts; underlying growth would have been low double-digits without reimbursement pressure.
- Adjusted EBITDA climbed 19% to $29.7M with margin expanding to 8.4%; gross margin improved to 22.8% despite elevated fuel costs and new site dilution.
- Company raised full-year 2026 guidance: revenue now $1.43B-$1.45B (from $1.40B-$1.42B); adjusted EBITDA $129M-$131M (from $123M-$127M).
- Guardian ended quarter with $90M cash and zero debt; management prioritizing M&A and greenfield expansion while awaiting Omnicare divestiture clarity.
- Management expects H2 2026 revenue to decline low single-digits YoY from IRA headwinds, but underlying growth to remain high single-digits with Q4 margin lift from vaccines.
Last Updated: 2026-08-06, 05:18 p/m
Read Full TranscriptEarnings
Latest Release
Aug 07, 2026
EPS / Forecast
0.29 / --
Revenue / Forecast
351.77M / --
Compare GRDN to Peers and Sector
Metrics to compare | GRDN | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipGRDNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 36.9x | −2.9x | −0.4x | |
PEG Ratio | 0.23 | 0.00 | 0.00 | |
Price/Book | 9.9x | 2.8x | 2.6x | |
Price / LTM Sales | 1.7x | 0.5x | 3.1x | |
Upside (Analyst Target) | 28.8% | 6.1% | 47.9% | |
Fair Value Upside | Unlock | 0.5% | 6.3% | Unlock |
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company’s individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Guardian Pharmacy Services (GRDN) Stock Price Today?
The Guardian Pharmacy Services stock price today is 38.43 USD.
What Stock Exchange Does Guardian Pharmacy Services Trade On?
Guardian Pharmacy Services is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Guardian Pharmacy Services?
The stock symbol for Guardian Pharmacy Services is "GRDN."
What Is the Guardian Pharmacy Services Market Cap?
As of today, Guardian Pharmacy Services market cap is 2.43B USD.
What Is Guardian Pharmacy Services's Earnings Per Share (TTM)?
The Guardian Pharmacy Services EPS (TTM) is 1.04.
When Is the Next Guardian Pharmacy Services Earnings Date?
Guardian Pharmacy Services will release its next earnings report on Aug 07, 2026.
From a Technical Analysis Perspective, Is GRDN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Guardian Pharmacy Services Stock Split?
Guardian Pharmacy Services has split 0 times.
How Many Employees Does Guardian Pharmacy Services Have?
Guardian Pharmacy Services has 3600 employees.
What is the current trading status of Guardian Pharmacy Services (GRDN)?
As of Aug 17, 2026, Guardian Pharmacy Services (GRDN) is trading at a price of 38.43 USD, with a previous close of 38.43 USD. The stock has fluctuated within a day range of 37.58 USD to 39.05 USD, while its 52-week range spans from 23.14 USD to 47.02 USD.
What Is Guardian Pharmacy Services (GRDN) Price Target According to Analysts?
The average 12-month price target for Guardian Pharmacy Services is 48.83 USD, with a high estimate of 50 USD and a low estimate of 47 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +27.07% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.